Madrigal pharmaceuticals posts quarterly loss per share of $1.80

Madrigal pharmaceuticals reports 2019 fourth quarter and full year financial results and highlights.madrigal pharmaceuticals inc quarterly loss per common share $1.80.
MDGL Ratings Summary
MDGL Quant Ranking